The Duffy antigen/receptor for chemokines (DARC) regulates prostate tumor growth

FASEB Journal

Volumn 20, Issue 1, 2006, Pages 59-64

  Shen, Hui ^a   Schuster, Rebecca ^a   Stringer, Keith F ^a   Waltz, Susan E ^a   Lentsch, Alex B ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

African American; Angiogenesis; Cancer; Endothelial cell

Indexed keywords

ALPHA CHEMOKINE; CHEMOKINE RECEPTOR; DUFFY ANTIGEN RECEPTOR FOR CHEMOKINE; UNCLASSIFIED DRUG;

AFRICAN AMERICAN; ANGIOGENESIS; ARTICLE; CANCER MORTALITY; CONTROLLED STUDY; ENDOTHELIUM CELL; ERYTHROCYTE; HUMAN; HUMAN CELL; MICROCIRCULATION; PARASITOSIS; PLASMODIUM VIVAX; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE TUMOR; PROTEIN BINDING; PROTEIN EXPRESSION; TUMOR GROWTH;

ADENOCARCINOMA; ANIMALS; BLOOD GROUP ANTIGENS; CELL LINE; CELL PROLIFERATION; CHEMOKINES; DUFFY BLOOD-GROUP SYSTEM; ERYTHROCYTES; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; MALE; MICE; MICE, TRANSGENIC; PROSTATIC NEOPLASMS; RECEPTORS, CELL SURFACE;

PLASMODIUM VIVAX;

EID: 30744470688     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.05-4764com     Document Type: Article

References (20)

1. Hadley, T. J., and Peiper, S. C. (1997) From malaria to chemokine receptor: the emerging physiologic role of the Duffy blood group antigen. Blood 89, 3077-3091
2. Darbonne, W. C., Rice, G. C., Mohler, M. A., Apple, T., Hebert, C. A., Valente, A. J., and Baker, J. B. (1991) Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J. Clin. Invest. 88, 1362-1369
3. Dawson, T. C., Lentsch, A. B., Wang, Z., Cowhig, J. E., Rot, A., Maeda, N., and Peiper, S. C. (2000) Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC). Blood 96, 1681-1684
4. Lee, J. S., Frevert, C. W., Wurfel, M. M., Peiper, S. C., Wong, V. A., Ballman, K. K., Ruzinski, J. T., Rhim, J. S., Martin, T. R., and Goodman, R. B. (2003) Duffy antigen facilitates movement of chemokine across the endothelium in vitro and promotes neutrophil transmigration in vitro and in vivo. J. Immunol. 170, 5244-5251
5. Szabo, M. C., Soo, K. S., Zlotnik, A., and Schall, T. J. (1995) Chemokine class differences in binding to the Duffy antigen-erythrocyte chemokine receptor. J. Biol. Chem. 270, 25348-25351
6. Strieter, R. M., Polverini, P. J., Kunkel, S. L., Arenberg, D. A., Burdick, M. D., Kasper, J., Dzuiba, J., Van Damme, J., Walz, A., Marriott, D., et al. (1995) The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J. Biol. Chem. 270, 27348-27357
7. + chemokine-induced angiogenic activity. J. Immunol. 165, 52669-52677
8. Moore, B. B., Arenberg, D. A., Stoy, K., Morgan, T., Addison, C. L., Morris, S. B., Glass, M., Wilke, C., Xue, Y. Y., Sitterding, S., et al. (1999) Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells. Am. J. Pathol. 154, 1503-1512
9. Shen, H., and Lentsch, A. B. (2004) Progressive dysregulation of transcription factors NF-κB and STAT1 in prostate cancer cells causes proangiogenic production of CXC chemokines. Am. J. Physiol. 286, C840-C847
10. Ferrer, F. A., Miller, L. J., Andrawis, R. I., Kurtzman, S. H., Albertsen, P. C., Laudone, V. P., and Kreutzer, D. L. (1998) Angiogenesis and prostate cancer: In vivo and in vitro expression of angiogenesis factors by prostate cancer cells. Urology 51, 161-167
11. Veltri, R. W., Miller, M. G., Zhao, G., Ng, A., Marley, G. M., Wright, G. L., Jr., Vessella, R. L., and Ralph, D. (1999) Interleukin-8 serum levels in patients with benign prostatic hyperplasia and prostate cancer. Urology 53, 139-147
12. Greenberg, N. M., DeMayo, F., Finegold, M. J., Medina, D., Tilley, W. D., Aspinall, J. O., Cunha, G. R., Donjacour, A. A., Matusik, R. J., and Rosen, J. M. (1995) Prostate cancer in a transgenic mouse. Proc. Natl. Acad. Sci. USA 92, 3439-3443
13. Modi, W. S., and Yoshimura, T. (1999) Isolation of novel GRO genes and a phylogenetic analysis of the CXC chemokine subfamily in mammals. Mol. Biol. Evol. 16, 180-193
14. Ries, L. A. G., Eisner, M. P., Kosary, C. L., Hankey, B. F., Miller, B. A., Clegg, L., Mariotto, A., Feuer, E. J., and Edwards, B. K. (2004) SEER cancer statistics review, 1975-2001, National Cancer Institute, Bethesda, MD
15. Tournamille, C., Colin, Y., Cartron, J. P., and Le Van Kim, C. (1995) Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat. Genet. 10, 224-228
16. Chaudhuri, A., Nielsen, S., Elkjaer, M. L., Zbrzezna, V., Fang, F., and Pogo, A. O. (1997) Detection of Duffy antigen in the plasma membranes and caveolae of vascular endothelial and epithelial cells of nonerythroid organs. Blood 89, 701-712
17. Middleton, J., Neil, S., Wintle, J., Clark-Lewis, I., Moore, H., Lam, C., Auer, M., Hub, E., and Rot, A. (1997) Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell 91, 385-395
18. Kashiwazaki, M., Tanaka, T., Kanda, H., Ebisuno, Y., Izawa, D., Fukuma, N., Akimitsu, N., Sekimizu, K., Monden, M., and Miyasaka, M. (2003) A high endothelial venule-expressing promiscuous chemokine receptor DARC can bind inflammatory, but not lymphoid, chemokines and is dispensable for lymphocyte homing under physiological conditions. Int. Immunol. 15, 1219-1227
19. Du, J., Luan, J., Liu, H., Daniel, T. O., Peiper, S., Chen, T. S., Yu, Y., Horton, L. W., Nanney, L. B., Strieter, R. M., et al. (2002) Potential role for Duffy antigen chemokine-binding protein in angiogenesis and maintenance of homeostasis in response to stress. J. Leukoc. Biol. 71, 141-153
20. Addison, C. L., Belperio, J. A., Burdick, M. D., and Strieter, R. M. (2004) Overexpression of the Duffy antigen receptor for chemokines (DARC) by NSCLC tumor cells results in increased tumor necrosis. BMC Cancer 4, 28